Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Jun;51(6):812–814. doi: 10.1136/ard.51.6.812

Granulomatous lipophagic panniculitis and temporal arteritis in a patient with cryptogenic chronic active hepatitis.

J E Naschitz 1, D Yeshurun 1, J Barth 1, I Misselevitch 1, J H Boss 1
PMCID: PMC1004755  PMID: 1616372

Abstract

An elderly woman receiving long term treatment with prednisone and azathioprine for cryptogenic chronic active hepatitis developed granulomatous lipophagic panniculitis and temporal arteritis. The lymphoplasmahistiocytic inflammatory reaction pattern is common to this patient's three diseases. It is suggested that an aberration of the defence mechanisms, immunological or otherwise, is responsible for this unusual occurrence. The triple association of chronic active hepatitis, granulomatous panniculitis and temporal arteritis has not been reported previously.

Full text

PDF
812

Images in this article

812Image
on p.812
813Image
on p.813
813Image
on p.813
814Image
on p.814

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen-Mersh T. G. Weber-Christian panniculitis and auto-immune disease: a case report. J Clin Pathol. 1976 Feb;29(2):144–149. doi: 10.1136/jcp.29.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andersson R. Giant cell arteritis. Acta Med Scand. 1988;224(3):193–194. doi: 10.1111/j.0954-6820.1988.tb19361.x. [DOI] [PubMed] [Google Scholar]
  3. Czaja A. J., Davis G. L., Ludwig J., Baggenstoss A. H., Taswell H. F. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology. 1983 Sep;85(3):713–717. [PubMed] [Google Scholar]
  4. Czaja A. J., Hay J. E., Rakela J. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc. 1990 Jan;65(1):23–30. doi: 10.1016/s0025-6196(12)62106-5. [DOI] [PubMed] [Google Scholar]
  5. Edge J., Dunger D. B., Dillon M. J. Weber-Christian panniculitis and chronic active hepatitis. Eur J Pediatr. 1986 Aug;145(3):227–229. doi: 10.1007/BF00446074. [DOI] [PubMed] [Google Scholar]
  6. Feizi T. Immunoglobulins in chronic liver disease. Gut. 1968 Apr;9(2):193–198. doi: 10.1136/gut.9.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Golding P. L., Smith M., Williams R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med. 1973 Dec;55(6):772–782. doi: 10.1016/0002-9343(73)90258-1. [DOI] [PubMed] [Google Scholar]
  8. Poppiti R. J., Jr, Margulies M., Cabello B., Rywlin A. M. Membranous fat necrosis. Am J Surg Pathol. 1986 Jan;10(1):62–69. doi: 10.1097/00000478-198601000-00007. [DOI] [PubMed] [Google Scholar]
  9. Reich K. A., Giansiracusa D. F., Strongwater S. L. Neurologic manifestations of giant cell arteritis. Am J Med. 1990 Jul;89(1):67–72. doi: 10.1016/0002-9343(90)90100-r. [DOI] [PubMed] [Google Scholar]
  10. Rynes R. I., Mika P., Bartholomew L. E. Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica. Ann Rheum Dis. 1977 Feb;36(1):88–90. doi: 10.1136/ard.36.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sonnenblick M., Nesher G., Rosin A. Nonclassical organ involvement in temporal arteritis. Semin Arthritis Rheum. 1989 Dec;19(3):183–190. doi: 10.1016/0049-0172(89)90031-0. [DOI] [PubMed] [Google Scholar]
  12. Winkelmann R. K., McEvoy M. T., Peters M. S. Lipophagic panniculitis of childhood. J Am Acad Dermatol. 1989 Nov;21(5 Pt 1):971–978. doi: 10.1016/s0190-9622(89)70285-1. [DOI] [PubMed] [Google Scholar]
  13. Winkelmann R. K. Panniculitis in connective tissue disease. Arch Dermatol. 1983 Apr;119(4):336–344. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES